The first GT Biopharma trade was made in Q2 2021.
Since then Ken Griffin bought shares four more times and sold shares on five occasions. The investor sold all their shares in Q1 2024 and doesn't own any shares in GT Biopharma anymore.
Avg closing price
Price range
Sold -1.93 Thousand shares
Q1 2024
Avg closing price
$2.82
Price range
$0.19
-
$5.13
New holding (+1.93 Thousand shares)
Q4 2023
Avg closing price
$0.24
Price range
$0.22
-
$0.28
Sold -1.24 Thousand shares
Q2 2023
Avg closing price
$0.35
Price range
$0.23
-
$0.55
New holding (+1.24 Thousand shares)
Q1 2023
Avg closing price
$0.76
Price range
$0.46
-
$1.05
Sold -2.03 Thousand shares
Q3 2022
Avg closing price
$2.55
Price range
$1.64
-
$3.16
Increased shares by 29.7% (+465 shares)
Q2 2022
Avg closing price
$2.53
Price range
$1.64
-
$3.11
Increased shares by 311.3% (+1.19 Thousand shares)
Q1 2022